Amerisource Health Services LLC is recalling 697 cartons of Meclizine Hydrochloride (meclizine) tablets because the product failed to meet its required tablet specifications. These tablets, used to treat motion sickness and vertigo, were distributed nationwide by American Health Packaging in both 50-tablet cartons and individual doses. While no incidents or injuries have been reported, consumers should check their medication to ensure it is not part of the affected batch.
The tablets failed to meet manufacturing specifications, which may affect the consistency or quality of the medication. This could result in the drug not performing as intended to manage symptoms like motion sickness or dizziness.
You have 2 options:
Distributed in (a) 50 Tablets [5 x 10] and (b) Individual Dose formats. Rx Only.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.